Helaina is pioneering modern nutrition with breast milk proteins developed outside the body via precision fermentation. The biotech company is writing the safety playbook on novel bioactive proteins and to help with this, Helaina hired a nutritional sciences...
The US Food and Drug Administration has selected James “Jim” Jones as the first Deputy Commissioner for Human Foods to lead the Agency’s proposed unified Human Foods Program (HFP).
The recent congressional hearing about CBD and subsequent ‘historic’ bicameral Request for Information (RFI) shows that hemp-derived CBD for use in dietary supplements has finally got the attention of Congress, said cbdMD’s CSO.
The class action lawsuit alleging that Walmart’s Spring Valley 1000 mg Fish Oil supplement is instead falsely labeled fish waste processed using industrial solvents and ethanol is moving forward.
The Natural Products Association (NPA) is seeking clarity on the labeling of fungi ingredients in dietary supplements, with a Citizen Petition requesting FDA to incorporate aspects of guidance from the American Herbal Products Association (AHPA).
The Norwegian fishing and biotech company has successfully achieved New Dietary Ingredient (NDI) status from the US Food and Drug Administration for its Lysoveta. Under the NDI, Aker BioMarine can market Lysoveta at 1.5 grams/day for the general adult...
Lawmakers and stakeholders assembled for a congressional hearing on July 27 to highlight how FDA’s refusal to regulate CBD is threatening consumer access to safe products.
By Aaron Skelton, President and Chief Executive Officer at Canadian Health Food Association (CHFA)
In an attempt to overhaul an already effective system, Health Canada's new regulatory measures for dietary supplements are inadvertently causing more harm than good – not only to Canadian consumers, retailers, and brands but also to U.S. suppliers.
Trade associations have long advocated for dietary supplements to be added to the list of qualified medical expenses to allow consumers to decide how to spend their pre-tax dollars.
The FDA has declined a request from South Carolina Congressman Jeff Duncan for a public hearing on NMN – nicotinamide mononucleotide – in dietary supplements.
Lisa Parks, RPh joined the Consumer Healthcare Products Association with over three decades of experience practicing pharmacy, managing organizational change initiatives at the FDA and overseeing scientific and regulatory affairs, today she embarks on...
The Board of the American Herbal Products Association will oppose FDA proposals to reorganize its dietary supplements program into a new Office of Food Chemical Safety, Dietary Supplements, and Innovation.
Fresh off a new Draft Guidance release, many are hopeful that Master Files would provide clarity on NDI filing requirements and provide protections for intellectual property. However, some point to issues with the NDI framework and say that must be solved...
FDA’s recent proposal to relocate the Office of Dietary Supplement Programs (ODSP) to a new Office of Food Chemical Safety, Dietary Supplements, and Innovation, is disturbing, says UNPA’s Loren Israelsen.
From a proposed reorganization of the Food & Drug Administration to progress (or not) on the NMN situation, there’s a lot going on in the dietary supplements industry. We caught up with Daniel Fabricant, PhD, president and CEO of the Natural Products...
Regulatory experts have launched new registration technology to "revolutionise" the time and energy-intensive global compliance process for supplement brands.
The dietary supplement industry is expressing concern over a proposed update to a Food and Drug Administration (FDA) reorganization that would relocate the current Office of Dietary Supplement Programs (ODSP) to a new office under its “Risk Management...
The need for certainty and preparedness emerged as crosscutting priorities among the general counsels, regulatory experts and research scientists gathered last week in New York City for the 11th Annual Legal, Regulatory and Compliance Forum on Dietary...
Fungi Perfecti, a supplier of mycelium-based supplements, has written an open letter to address the citizen petition filed by mushroom extract company Nammex, which requested that the Food and Drug Administration act to ensure proper labeling of fungi...
North American Reishi Ltd (“Nammex”) has filed a Citizen Petition with the FDA on the labeling and sale of food and supplements containing fungal ingredients.
With the ongoing theme of safety, FDA recently addressed CBD. While offering up several potential scenarios, the Agency said the CBD marketplace ultimately rests in the hands of Congress.
NutraIngredients-USA caught up with Cara Welch, PhD, Director of FDA's Office of Dietary Supplement Programs. Welch talked inspections, made the case for MPL and hinted NDI guidance is on the way.
NutraIngredients-USA caught up with CRN’s Steve Mister at SupplySide East to discuss new research, top priorities for the year and what they hope to see from FDA this year.
The American Herbal Products Association (AHPA) has called out Amazon for allegedly prohibiting the sale of products containing Pinellia ternata based on an inaccurate adulteration allegation issued by the U.S. Food & Drug Administration (FDA).
The raft of letters puts advertisers on notice that they should avoid deceiving consumers by making product claims that cannot be substantiated–or face hefty fines.
Today we can reveal the first wave of speakers confirmed for Probiota Americas, the must-attend conference bridging the business and science of microbiome modulation for human health.
CBD sellers were holding onto hope that the FDA would regulate CBD in order to stabilize the industry and give customers confidence, but the lack of guidance has left business owners like Landis feeling trapped.
Regulatory issues, high chargeback rates, reputation and fraud all make dietary supplements 'high-risk.' So when it comes to accepting online credit card payments, traditional financial institution don't want to go through the hassle.
With expert speakers confirmed from NOW, Nouri, Postbiotics+, Microba, Zbiotics, NC State University, FDA, Health Canada, the University of Nebraska-Lincoln, and more, the upcoming Probiota Americas is not to be missed.
In a letter addressed to the 118th Congress last week, supplement company Ritual is appealing to lawmakers to address key safety and efficacy issues in a bourgeoning dietary supplement industry.
The Empire State is the latest to introduce legislation aimed at restricting access to weight management supplements, joining Maryland, California, New York, Colorado and elsewhere.
Does the legislation have legs or is it just for optics? Stakeholders agree the bills are a step in a positive direction, but what impact they will have, if any, is yet to be seen.
The Commission calls out disease prevention ads, weight-loss products and MLMs as it investigates the inner workings of social media and its function in deceptive online advertising.
Are supply chains still causing problems for businesses? What are the hottest ingredients and most sought-after product claims? And do people really think about FDA’s recent actions against ingredients like NAC and NMN?
The Natural Products Association is hoping the US Food & Drug Administration is responsive to its recent Citizen’s Petition on the status of NMN, but if it’s not then other options are being considered, Dr Daniel Fabricant, NPA’s CEO tells NutraIngredients-USA.
A new Citizen’s Petition is requesting the FDA reevaluate the status of NMN or exercise Enforcement Discretion on the Drug Exclusion Clause for the ingredient.
The US Food and Drug Administration (FDA) has unveiled a new Dietary Supplement Ingredient Directory, providing detailed information on 27 ingredients that the Agency states are used in products marketed as dietary supplements.
Delegate registration is now open for Probiota Americas in Chicago, with the event kicking off with a panel with CEOs from some of the most iconic brands in the US dietary supplements space.
The Center for Contemporary Equine Studies has filed suit against retailers for selling supplements made from donkey skin, which it says is illegal in the state of California.
From authentication and identification of botanicals to approached to establishing safety and efficacy, the 21st International Conference on the Science of Botanicals (ICSB) provides stakeholders in the botanicals space a unique opportunity to learn and...
Once seen as a legal alternative to marijuana, the Agency is making it clear that synthetic cannabinoids are illegal under the Controlled Substances Act.